Quesada-Arias, Luisa D
155  results:
Search for persons X
?
4

HEp-2 titers and outcomes:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/figure/HEp-2_titers_and_outcomes_/17070791.  , 2021
 
?
5

S1 Dataset -:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/dataset/S1_Dataset_-/17070773.  , 2021
 
?
6

HEp-2 indirect Immunofluorescence (IFA) of IPF Plasma:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/figure/HEp-2_indirect_Immunofluorescence_IFA_of_IPF_Plasma_/17070785.  , 2021
 
?
7

Patient demographic characteristics:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/dataset/Patient_demographic_characteristics_/17070803.  , 2021
 
?
8

S1 File -:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/journal_contribution/S1_File_-/17070767.  , 2021
 
?
9

Associations with anti-Hep-2 titers at initiation of therap:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/dataset/Associations_with_anti-Hep-2_titers_at_initiation_of_therapy_/17070812.  , 2021
 
?
10

Triple-modality autoantibody reduction regimen:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/dataset/Triple-modality_autoantibody_reduction_regimen_/17070797.  , 2021
 
?
11

Overall survival and responses to autoantibody reduction th..:

Tejaswini Kulkarni (716851) ; Vincent G. Valentine (7465325) ; Fei Fei (794241)...
https://figshare.com/articles/figure/Overall_survival_and_responses_to_autoantibody_reduction_therapy_/17070779.  , 2021
 
?
 
1-15